Elisabet Deig

546 citations
12 papers · 258 indexed · h-index 6
Topics
HIV/AIDS drug development and treatment (8 papers)HIV Research and Treatment (6 papers)HIV-related health complications and treatments (6 papers)

In The Last Decade

Elisabet Deig

12 papers receiving 251 citations

Peers

Elisabet Deig
Comparison fields: 5 of 46
  • Virology 126
  • Infectious Diseases 120
  • Emergency Medicine 117
  • Oncology 59
  • Epidemiology 57
Replace Elgin Green with:
Elgin Green United States
Gràcia Mateo Spain
Saadia Mokhtari France
Mar Gutiérrez Spain
Chiara Montrucchio Italy
Guglielmo Marco Migliorino Italy
Sophie Pakianather France
Juan Tiraboschi Spain
Corine Chazallon France
María Lagarde Spain
Elisabet Deig relative to Elgin Green United States Elgin Green's profile →
Citations per field
00.5×2.7×
Elgin Green · 1×
Citations per year

Countries citing papers authored by Elisabet Deig

Since Specialization
Citations

This map shows the geographic impact of Elisabet Deig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabet Deig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabet Deig more than expected).

Fields of papers citing papers by Elisabet Deig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabet Deig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabet Deig. The network helps show where Elisabet Deig may publish in the future.

Co-authorship network of co-authors of Elisabet Deig

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabet Deig. A scholar is included among the top collaborators of Elisabet Deig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabet Deig. Elisabet Deig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 2
2 3
3 2
4 4
5 22
6 60
7 25
8 3
9 1
10 7
11 7
12 122

About Elisabet Deig

Elisabet Deig is a scholar working on Virology, Emergency Medicine and Infectious Diseases, having authored 12 papers that have together received 258 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers) and HIV-related health complications and treatments (6 papers). The work is most often cited by research in Virology (126 citations), Emergency Medicine (117 citations) and Infectious Diseases (120 citations). Elisabet Deig has collaborated with scholars based in Spain, Palestinian Territory and Denmark. Frequent co-authors include Enric Pedrol, Glòria Garrabou, Óscar Miró, Estebán Martínez, Sònia López, Ana Milinkovic, F Cardellach, JM Gatell, Jordi Casademont and Peré Domingo. Their work appears in journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and JAIDS Journal of Acquired Immune Deficiency Syndromes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026